{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:57:18Z","timestamp":1787500638224,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5T32CA126607-12"],"award-info":[{"award-number":["5T32CA126607-12"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1245\/s10434-024-16116-9","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T11:03:03Z","timestamp":1729767783000},"page":"671-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of the Uninvolved Uterus and Adnexa During Routine Pelvic Peritonectomy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Varies by Histology and Menopausal Status: An International Survey of Peritoneal Surface Malignancy Surgeons"],"prefix":"10.1245","volume":"32","author":[{"given":"Nolan M.","family":"Winicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon N.","family":"Radomski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella S.","family":"Florissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Wethington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Esquivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8968-9710","authenticated-orcid":false,"given":"Jonathan B.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"16116_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.sla.0000133183.15705.71","volume":"240","author":"O Glehen","year":"2004","unstructured":"Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004;240:278\u201385. https:\/\/doi.org\/10.1097\/01.sla.0000133183.15705.71.","journal-title":"Ann Surg."},{"key":"16116_CR2","doi-asserted-by":"publisher","first-page":"100610","DOI":"10.1016\/j.gore.2020.100610","volume":"33","author":"MJ Riggs","year":"2020","unstructured":"Riggs MJ, Lin M, Kim J, Pandalai P, Dietrich CS 3rd. Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers. Gynecol Oncol Rep. 2020;33:100610. https:\/\/doi.org\/10.1016\/j.gore.2020.100610.","journal-title":"Gynecol Oncol Rep."},{"key":"16116_CR3","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1245\/s10434-023-13608-y","volume":"30","author":"IS Florissi","year":"2023","unstructured":"Florissi IS, Radomski SN, Winicki NM, Shou B, Johnston FM, Greer JB. Prophylactic hysterectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for high-grade tumors is associated with fewer pelvic recurrences. Ann Surg Oncol. 2023;30:4576\u20138. https:\/\/doi.org\/10.1245\/s10434-023-13608-y.","journal-title":"Ann Surg Oncol."},{"key":"16116_CR4","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1080\/01443615.2022.2055453","volume":"42","author":"D Papageorgiou","year":"2022","unstructured":"Papageorgiou D, Diakosavvas M, Angelou K, et al. Fertility outcomes after treatment with intraperitoneal chemotherapy. J Obstet Gynaecol. 2022;42:1626\u201334. https:\/\/doi.org\/10.1080\/01443615.2022.2055453.","journal-title":"J Obstet Gynaecol."},{"key":"16116_CR5","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/jco.2018.78.1914","volume":"36","author":"K Oktay","year":"2018","unstructured":"Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36:1994\u20132001. https:\/\/doi.org\/10.1200\/jco.2018.78.1914.","journal-title":"J Clin Oncol."},{"key":"16116_CR6","unstructured":"NCCN. Releases statement on preservation of fertility planning options. 2024. https:\/\/www.nccn.org\/news\/newsinfo.aspx?NewsID=2024"},{"key":"16116_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/1471-2407-12-278","volume":"12","author":"W Li","year":"2012","unstructured":"Li W, Wang H, Wang J, Lv F, Zhu X, Wang Z. Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients. BMC Cancer. 2012;12:278. https:\/\/doi.org\/10.1186\/1471-2407-12-278.","journal-title":"BMC Cancer."},{"key":"16116_CR8","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1007\/s00384-021-04012-7","volume":"36","author":"R van der Meer","year":"2021","unstructured":"van der Meer R, Bakkers C, Rostamkhan E, de Hingh I, Roumen R. Ovarian metastases from colorectal cancer in young women: a systematic review of the literature. Int J Colorectal Dis. 2021;36:2567\u201375. https:\/\/doi.org\/10.1007\/s00384-021-04012-7.","journal-title":"Int J Colorectal Dis."},{"key":"16116_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/codi.14057","volume":"20","author":"MB Bignell","year":"2018","unstructured":"Bignell MB, Mehta AM, Alves S, et al. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer. Colorect Dis. 2018;20:704\u201310. https:\/\/doi.org\/10.1111\/codi.14057.","journal-title":"Colorect Dis."},{"key":"16116_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ygyno.2005.05.028","volume":"98","author":"A Ayhan","year":"2005","unstructured":"Ayhan A, Guvenal T, Salman MC, Ozyuncu O, Sakinci M, Basaran M. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol. 2005;98:235\u201341. https:\/\/doi.org\/10.1016\/j.ygyno.2005.05.028.","journal-title":"Gynecol Oncol."},{"key":"16116_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejogrb.2009.11.011","volume":"149","author":"WY Kim","year":"2010","unstructured":"Kim WY, Kim TJ, Kim SE, et al. The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries. Eur J Obstet Gynecol Reprod Biol. 2010;149:97\u2013101. https:\/\/doi.org\/10.1016\/j.ejogrb.2009.11.011.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"16116_CR12","doi-asserted-by":"publisher","first-page":"881510","DOI":"10.3389\/fsurg.2022.881510","volume":"9","author":"F Fu","year":"2022","unstructured":"Fu F, Tang H, Lu Y, Lu D, Ma R. Prognosis for young females with pseudomyxoma peritonei of appendiceal origin and unilateral or bilateral ovaries preserved during cytoreductive surgery. Front Surg. 2022;9:881510. https:\/\/doi.org\/10.3389\/fsurg.2022.881510.","journal-title":"Front Surg."},{"key":"16116_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4999\/uhod.161336","volume":"26","author":"Z Arik","year":"2016","unstructured":"Arik Z, Oz M, Dizdar O, et al. Cytoreductive surgery for intestinal cancer patients metastatic to ovaries presenting as primary ovarian cancer. UHOD Uluslararasi Hematoloji Onkoloji Dergisi. 2016;26:110\u20135. https:\/\/doi.org\/10.4999\/uhod.161336.","journal-title":"UHOD Uluslararasi Hematoloji Onkoloji Dergisi."},{"key":"16116_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110:275\u201384. https:\/\/doi.org\/10.1002\/jso.23633.","journal-title":"J Surg Oncol."},{"key":"16116_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1245\/s10434-011-1840-y","volume":"19","author":"H El Halabi","year":"2012","unstructured":"El Halabi H, Gushchin V, Francis J, et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012;19:110\u20134. https:\/\/doi.org\/10.1245\/s10434-011-1840-y.","journal-title":"Ann Surg Oncol."},{"key":"16116_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/s1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366. https:\/\/doi.org\/10.1016\/s1470-2045(20)30599-4.","journal-title":"Lancet Oncol."},{"key":"16116_CR17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/dcr.0000000000000791","volume":"60","author":"AM Mehta","year":"2017","unstructured":"Mehta AM, Bignell MB, Alves S, et al. Risk of ovarian involvement in advanced colorectal or appendiceal tumors involving the peritoneum. Dis Colon Rectum. 2017;60:691\u20136. https:\/\/doi.org\/10.1097\/dcr.0000000000000791.","journal-title":"Dis Colon Rectum."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16116-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16116-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16116-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T12:03:25Z","timestamp":1735905805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16116-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["16116"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16116-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Shannon N. Radomski received financial support from the National Cancer Institute (NCI) grant 5T32CA126607-12 and the American College of Surgeons Resident Research Scholarship. Stephanie Wethington - In the 36 months prior to publication, I had 6 weeks of employment by Astrazeneca.\u00a0Olivier Glehen - consultant for GAMIDA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}